23andMe Holding Co. stock is up 19.63% since 30 days ago. The next earnings date is Feb 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 December’s closed higher than November. In the last 4 Unusual Options Trades, there were 3 PUTs, 1 CALL.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
25 Oct 14:39 | 17 Jan, 2025 | 1.00 | 253 | ||
25 Oct 15:17 | 17 Jan, 2025 | 1.00 | 253 | ||
07 Nov 15:07 | 17 Jan, 2025 | 1.00 | 3080 | ||
09 Nov 16:59 | 17 Jan, 2025 | 4.00 | 44 |
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The company was founded in 2006 and is headquartered in South San Francisco, California.